- Home
- WK vs AXSM Comparison
WK vs AXSM Comparison
Compare WK & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WK
- AXSM
- Stock Information
- Founded
- WK 2008
- AXSM 2012
- Country
- WK United States
- AXSM United States
- Employees
- WK N/A
- AXSM N/A
- Industry
- WK Computer Software: Prepackaged Software
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- WK Technology
- AXSM Health Care
- Exchange
- WK Nasdaq
- AXSM Nasdaq
- Market Cap
- WK 4.3B
- AXSM 4.4B
- IPO Year
- WK 2014
- AXSM 2015
- Fundamental
- Price
- WK $94.83
- AXSM $98.19
- Analyst Decision
- WK Buy
- AXSM Strong Buy
- Analyst Count
- WK 5
- AXSM 14
- Target Price
- WK $103.20
- AXSM $124.93
- AVG Volume (30 Days)
- WK 423.9K
- AXSM 536.9K
- Earning Date
- WK 11-06-2024
- AXSM 11-12-2024
- Dividend Yield
- WK N/A
- AXSM N/A
- EPS Growth
- WK N/A
- AXSM N/A
- EPS
- WK N/A
- AXSM N/A
- Revenue
- WK $705,444,000.00
- AXSM $338,457,000.00
- Revenue This Year
- WK $19.91
- AXSM $40.67
- Revenue Next Year
- WK $16.07
- AXSM $69.27
- P/E Ratio
- WK N/A
- AXSM N/A
- Revenue Growth
- WK 16.18
- AXSM 51.47
- 52 Week Low
- WK $65.47
- AXSM $60.28
- 52 Week High
- WK $105.00
- AXSM $105.00
- Technical
- Relative Strength Index (RSI)
- WK 69.25
- AXSM 61.45
- Support Level
- WK $89.39
- AXSM $90.86
- Resistance Level
- WK $95.58
- AXSM $105.00
- Average True Range (ATR)
- WK 2.95
- AXSM 4.06
- MACD
- WK 0.24
- AXSM 0.44
- Stochastic Oscillator
- WK 92.57
- AXSM 64.04
About WK Workiva Inc.
Workiva Inc is a cloud-native platform that simplifies the complexities of reporting and compliance. Workiva platform empowers customers by connecting and transforming data from hundreds of enterprise resource planning (ERP), human capital management (HCM), and customer relationship management (CRM) systems, as well as other third-party cloud and on-premise applications. Customers use the platform to create, review and publish data-linked documents and reports with greater control, consistency, accuracy, and productivity and it is also used for SEC Filings. It provides to more than 6,000 organizations across the globe with SaaS platform solutions to help solve some of the most complex reporting and disclosure challenges.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.